Air Evacuation under High-Level Biosafety Containment
Author Information
Author(s): George W. Christopher, Edward M. Eitzen, Jr.
Primary Institution: U.S. Army Medical Research Institute of Infectious Diseases
Hypothesis
How can patients with potentially lethal, contagious infections be safely evacuated under high-level biosafety containment?
Conclusion
The U.S. Army Medical Research Institute of Infectious Diseases has developed an aeromedical isolation team to safely transport patients with highly contagious diseases while minimizing risks to air crews and civilians.
Supporting Evidence
- The aeromedical isolation team can deploy within 6 to 12 hours of notification.
- The team can transport and manage one patient per team, with two teams able to operate simultaneously.
- Isolators have been used to treat patients with suspected Ebola, Lassa, and Marburg hemorrhagic fevers.
Takeaway
This study talks about a special team that helps move sick people who might have dangerous infections safely, so they don't make others sick.
Methodology
The aeromedical isolation team uses specialized equipment and procedures to transport patients with highly contagious diseases safely.
Limitations
The use of isolators for in-patient care has been questioned, and their use in hospitals is not recommended.
Want to read the original?
Access the complete publication on the publisher's website